Southborough, MA, United States of America

William C Shakespeare

USPTO Granted Patents = 36 (Patent Applications = 31)

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 19)

Average Co-Inventor Count = 6.9

ph-index = 11

Forward Citations = 291(Granted Patents)

Location History:

Framingham, MA (US) (2002 - 2006)
Southbourgh, MA (US) (2016)
Cambridge, MA (US) (2021 - 2023)
Southborough, MA (US) (2004 - 2024)

Company Filing History:

34 out of 69

Ariad Pharmaceuticals, Inc.

Takeda Pharmaceutical Company Limited

patents

Years Active: 2002-2024

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11958850 - Heteroaryl compounds for kinase inhibition (2024-04-16),

2. 11753404 - Aminothiazole compounds as c-Kit inhibitors (2023-09-12),

3. 11117883 - Benzimidazole compounds as c-Kit inhibitors (2021-09-14),

4. 11001580 - Aminothiazole compounds as c-Kit inhibitors (2021-05-11),

5. 10227342 - Heteroaryl compounds for kinase inhibition (2019-03-12),

6. 9834571 - Compounds for inhibiting cell proliferation in EGFR-driven cancers (2017-12-05),

7. 9834521 - Choline kinase inhibitors (2017-12-05),

8. 9834518 - Compounds for inhibiting cell proliferation in EGFR-driven cancers (2017-12-05),

9. 9796712 - Heteroaryl compounds for kinase inhibition (2017-10-24),

10. 9611283 - Methods for inhibiting cell proliferation in ALK-driven cancers (2017-04-04),

11. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors (2016-03-08),

12. 9273077 - Phosphorus derivatives as kinase inhibitors (2016-03-01),

13. 9090561 - Acetylenic heteroaryl compounds (2015-07-28),

14. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors (2015-05-12),

15. 9012462 - Phosphorous derivatives as kinase inhibitors (2015-04-21),

Title: Exploring the Innovations of Inventor William C Shakespeare

Introduction: William C Shakespeare, a prolific inventor based in Southborough, MA, has left a significant mark in the field of pharmaceutical innovations with a total of 36 patents to his name. Let's delve into his latest patents, career highlights, collaborations, and the impact of his work.

Latest Patents: Among his latest patents, William C Shakespeare has presented groundbreaking inventions such as "Heteroaryl compounds for kinase inhibition." These compounds and pharmaceutical compositions play a crucial role in modulating kinase activity, including mutant EGFR and mutant HER2 kinase activity. Additionally, his invention of "Aminothiazole compounds as c-Kit inhibitors" showcases his expertise in developing treatments for cancers and other serine-threonine kinase-mediated diseases.

Career Highlights: William C Shakespeare has showcased his innovation prowess in esteemed companies such as Ariad Pharmaceuticals, Inc. and AstraZeneca AB. His patent portfolio reflects a deep understanding of pharmaceutical research and a commitment to developing novel solutions for complex diseases.

Collaborations: Throughout his career, William C Shakespeare has collaborated with brilliant minds in the industry. Notable coworkers such as Yihan Wang and David C Dalgarno have contributed to the success of his inventions through their expertise and dedication to scientific advancement.

Conclusion: In conclusion, William C Shakespeare's contributions to the field of pharmaceutical innovations are commendable. His array of patents, career achievements, and fruitful collaborations underline his position as a pioneering inventor making a difference in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.